Bristol-Myers Squibb (BMY) stands out as one of the most undervalued biotech stocks, backed by strong financials and a robust ...

The March 19 edition of the SBJ Tech newsletter features a chat with NCAA VP, Chief Technology Officer John Macrina on his ...

Struggling Pacific Science Center envisions a new hands-on main attraction, explores real estate deal in bid to stay afloat.

We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a ...

Bristol Myers (BMY)’ treatment of small cell lung cancer, atigotatug plus nivolumab fixed dose combination, received FDA orphan designation, ...

AGD members are using the population-level insights to uncover novel drug targets SAN DIEGO, /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC (NashBio), a leading clinical ...

Qualified Digital, which is backed by Stella Point Capital, has acquired Xpediant Digital, a Houston-based provider of content supply chain automations for pharma and life sciences. No financial terms ...

Applied Therapeutics, Inc. (Nasdaq: APLT), a biopharmaceutical company dedicated to creating transformative treatments for rare disease, today announced the appointment of Todd F. Baumgartner, MD, MPH ...

Chinese trade officials are stepping up a charm offensive as Beijing seeks to assure global business leaders of the economy's ...

The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...

Active surveillance (AS) following a complete clinical response to neoadjuvant chemoradiotherapy was noninferior to standard ...

Bristol-Myers Squibb offers 17.25% upside with strong growth prospects, cost-saving initiatives & an undervalued stock. Learn ...